FDA daily

FDA daily for Tuesday, February 3, 2026

In this issue: 17 approvals, 12 device recalls, 13 device decisions and 180 label changes. 2 items touch categories MedGrid carries, and they come first.

For MedGrid's categories

Items in this issue that name a product category sold on MedGrid. Each links to its full FDA record; the chip opens that category's federal and state rules.

Drug and biologic approvals

FDA date:

On Tue, Jan 27 FDA approved 5 new applications (0 brand or biologic, 5 generic) and 12 supplements to existing ones.

  • MESNA

    EUGIA PHARMA · MESNA

    ANDA220518Generic (ANDA)Prescription
  • DEFLAZACORT

    SUN PHARM INDS INC · DEFLAZACORT

    ANDA219930Generic (ANDA)Prescription
  • PROPRANOLOL HYDROCHLORIDE

    MANKIND PHARMA · PROPRANOLOL HYDROCHLORIDE

    ANDA216663Generic (ANDA)Prescription
  • TAPENTADOL HYDROCHLORIDE

    EPIC PHARMA LLC · TAPENTADOL HYDROCHLORIDE

    ANDA214378Generic (ANDA)Prescription
  • FIDAXOMICIN

    TORRENT · FIDAXOMICIN

    ANDA220374Generic (ANDA)Prescription
Browse drug and biologic approvals in FDA data →

Device recalls

FDA date:

FDA posted 12 device recalls from 4 firms on Tue, Jan 27.

Browse device recalls in FDA data →

Device clearances and approvals

FDA date:

FDA decided 9 510(k)s and 4 PMA decisions on Tue, Jan 20.

Browse device clearances and approvals in FDA data →

Label updates

FDA date:

180 drug labels took effect on Tue, Jan 20; 5 of the 25 read for this issue are for products in MedGrid's categories. Below: those, and labels carrying a boxed warning.

Browse label updates in FDA data →

How the FDA daily is written

Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug and device recalls, and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Complete response letters appear the day after FDA publishes a batch.

Subscribe with any feed reader, or point an email tool at the RSS feed to send each issue as a newsletter. Search any drug, device or company across every FDA dataset in the FDA data explorer.

Read FDA's day. Stock your practice.

Join free with your NPI: wholesale pricing from verified vendors, with the FDA and state rules for each category one click away.

Join as a DoctorSell on MedGrid

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.